Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Gynecol Oncol. 2010 Jun 9;118(3):251–257. doi: 10.1016/j.ygyno.2010.05.010

Table 4. Endometrioid miRNA signatures compared to carcinosarcoma miRNA signatures.

Upregulated Fold Change Nominal P Value Adjusted P. Value (FDR)
miR-518b 2.4 2.6E-05 1.4E-03
miR-133a 2.5 3.6E-04 8.3E-03
Downregulated
miR-19a -7.0 1.4E-07 2.2E-05
miR-19b -5.7 2.8E-06 2.2E-04
miR-301 -6.2 4.9E-05 1.9E-03
miR-146b -4.6 1.4E-04 4.3E-03
miR-335 -5.1 3.8E-04 8.3E-03
miR-487b -4.8 8.0E-04 1.6E-02
miR-20b -5.2 1.2E-03 2.0E-02
miR-452 -4.8 2.7E-03 4.0E-02